HUMAN GENOME SCIENCES INC Net Change in Cash
HUMAN GENOME SCIENCES INC reported Net Change in Cash of -$52.09 million for the 6-month period ending 2012-06-30, per its 10-Q filed 2012-07-26.
Discontinued › Cash Flow
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2012-07-26
- HUMAN GENOME SCIENCES INC cash and cash equivalents, period increase (decrease) for the quarter ending 2012-06-30 was $741.00K, a 87.07% decline year-over-year.
- HUMAN GENOME SCIENCES INC cash and cash equivalents, period increase (decrease) for the quarter ending 2012-03-31 was -$52.83M.
- HUMAN GENOME SCIENCES INC cash and cash equivalents, period increase (decrease) for the quarter ending 2011-12-31 was $364.39M.
- HUMAN GENOME SCIENCES INC cash and cash equivalents, period increase (decrease) for the quarter ending 2011-09-30 was -$16.03M.
- HUMAN GENOME SCIENCES INC cash and cash equivalents, period increase (decrease) for fiscal 2011 was $246.36M.
- HUMAN GENOME SCIENCES INC cash and cash equivalents, period increase (decrease) for fiscal 2010 was -$411.98M, a 174.58% decline from fiscal 2009.
- HUMAN GENOME SCIENCES INC cash and cash equivalents, period increase (decrease) for fiscal 2009 was $552.42M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2012-06-30 | $741.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-26 | -$52.09M 10-Q · filed 2012-07-26 | $312.30M derived: sum of 3 quarters · filed 2012-07-26 | $296.26M derived: sum of 4 quarters · filed 2012-07-26 |
| 2012-03-31 | -$52.83M 10-Q · filed 2012-04-26 | $311.56M derived: sum of 2 quarters · filed 2012-04-26 | $295.52M derived: sum of 3 quarters · filed 2012-04-26 | $301.26M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-12-31 | $364.39M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $348.36M derived: sum of 2 quarters · filed 2012-02-28 | $354.09M derived: sum of 3 quarters · filed 2012-07-26 | $246.36M 10-K · filed 2012-02-28 |
| 2011-09-30 | -$16.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28 | -$10.30M derived: sum of 2 quarters · filed 2012-07-26 | -$118.03M 10-Q · filed 2011-10-28 | -$192.70M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-06-30 | $5.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-26 | -$102.00M 10-Q · filed 2012-07-26 | -$176.67M derived: sum of 3 quarters · filed 2012-07-26 | -$227.22M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-03-31 | -$107.73M 10-Q · filed 2012-04-26 | -$182.40M derived: sum of 2 quarters · filed 2012-04-26 | -$232.95M derived: sum of 3 quarters · filed 2012-04-26 | -$278.61M derived: sum of 4 quarters · filed 2012-04-26 |
| 2010-12-31 | -$74.67M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | -$125.22M derived: sum of 2 quarters · filed 2012-02-28 | -$170.88M derived: sum of 3 quarters · filed 2012-02-28 | -$411.98M 10-K · filed 2012-02-28 |
| 2010-09-30 | -$50.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28 | -$96.21M derived: sum of 2 quarters · filed 2011-10-28 | -$337.31M 10-Q · filed 2011-10-28 | |
| 2010-06-30 | -$45.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-28 | -$286.75M 10-Q · filed 2011-07-28 | ||
| 2010-03-31 | -$241.10M 10-Q · filed 2011-04-29 | |||
| 2009-12-31 | $552.42M 10-K · filed 2012-02-28 |